1. Gerber JE, Cawthon B. Overdose and death with olanzapine: two case reports. Am J Forensic Med Pathol. 2000 Sep;21(3):249-51. doi: 10.1097/00000433-200009000-00013. PMID: 10990286. [cited 2022 June 27]
2. Report from US Justice Dept #09-038: Eli Lilly amd Company Agrees to Pay $1.415 Billion to Resolve Allegations of Off-label Promotion of Zyprexa published 2009 [cited 2022 June 27]
3. FDA ZYPREXA (Olanzapine) label [cited 2022 June 27]
4. Alicia Ruelaz Maher, Margaret Maglione, Steven Bagley, Marika Suttorp, Jian-Hui Hu, Brett Ewing, Zhen Wang, Martha Timmer, David Sultzer, Paul G. Shekelle. Efficacy and Comparative Effectiveness of Atypical Antipsychotic Medications for Off-Label Uses in Adults: A Systematic Review and Meta-analysis. JAMA, 2011; 306 (12): 1359-1369 [cited 2022 June 27]
5. Aucoin M, LaChance L, Clouthier SN, Cooley K. Dietary modification in the treatment of schizophrenia spectrum disorders: A systematic review. World J Psychiatry. 2020 Aug 19;10(8):187-201. doi: 10.5498/wjp.v10.i8.187. PMID: 32874956; PMCID: PMC7439299. [cited 2022 June 27]
6. Aucoin M, LaChance L, Cooley K, Kidd S. Diet and Psychosis: A Scoping Review. Neuropsychobiology. 2020;79(1):20-42. doi: 10.1159/000493399. Epub 2018 Oct 25. PMID: 30359969. [cited 2022 June 27]
7. Głąbska D, Guzek D, Groele B, Gutkowska K. Fruit and Vegetable Intake and Mental Health in Adults: A Systematic Review. Nutrients. 2020;12(1):115. Published 2020 Jan 1. doi:10.3390/nu12010115 [cited 2022 June 27]
8. Ho BC, Andreasen NC, Ziebell S et al., “Long-term Antipsychotic Treatment and Brain Volume” JAMA [online] Feb 2011 [cited 2022 June 27]
9. Włodarczyk A, Wiglusz MS, Cubała WJ. Ketogenic diet for schizophrenia: Nutritional approach to antipsychotic treatment. Med Hypotheses. 2018 Sep;118:74-77. doi: 10.1016/j.mehy.2018.06.022. Epub 2018 Jun 20. PMID: 30037619. [cited 2022 June 27]
10. Rathod S, Phiri P, Kingdon D. Cognitive behavioral therapy for schizophrenia. Psychiatr Clin North Am. 2010 Sep;33(3):527-36. doi: 10.1016/j.psc.2010.04.009. PMID: 20599131. [cited 2022 June 27]
11. Severance EG, Yolken RH, Eaton WW. Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling. Schizophr Res. 2016;176:23–35. [cited 2022 June 27]
12. Ganguly P, Soliman A, Moustafa AA. Holistic Management of Schizophrenia Symptoms Using Pharmacological and Non-pharmacological Treatment. Front Public Health. 2018;6:166. Published 2018 Jun 7. doi:10.3389/fpubh.2018.00166 [cited 2021 Dec 7]
13. Moore E, Mancuso SG, Slade T, Galletly C, Castle DJ. The impact of alcohol and illicit drugs on people with psychosis: the second Australian National Survey of Psychosis. Aust N Z J Psychiatry. 2012 Sep;46(9):864-78. doi: 10.1177/0004867412443900. Epub 2012 Apr 3. PMID: 22472772. [cited 2021 Dec 7]
14. Hasan A, von Keller R, Friemel CM, Hall W, Schneider M, Koethe D, Leweke FM, Strube W, Hoch E. Cannabis use and psychosis: a review of reviews. Eur Arch Psychiatry Clin Neurosci. 2020 Jun;270(4):403-412. doi: 10.1007/s00406-019-01068-z. Epub 2019 Sep 28. PMID: 31563981.[cited 2021 Dec 7]
15. Peet M. Omega-3 polyunsaturated fatty acids in the treatment of schizophrenia. Isr J Psychiatry Relat Sci. 2008;45(1):19-25. PMID: 18587166. [cited 2021 Dec 7]
16. Assisi A, Banzi R, Buonocore C, Capasso F, Di Muzio V, Michelacci F, Renzo D, Tafuri G, Trotta F, Vitocolonna M, Garattini S. Fish oil and mental health: the role of n-3 long-chain polyunsaturated fatty acids in cognitive development and neurological disorders. Int Clin Psychopharmacol. 2006 Nov;21(6):319-36. doi: 10.1097/01.yic.0000224790.98534.11. PMID: 17012979. [cited 2021 Dec 7]
17. Hoenders HJR, Bartels-Velthuis AA, Vollbehr NK, Bruggeman R, Knegtering H, de Jong JTVM. Natural Medicines for Psychotic Disorders: A Systematic Review. J Nerv Ment Dis. 2018;206(2):81-101. doi:10.1097/NMD.0000000000000782 [cited 2021 Dec 7]
18. Hedges DW, Woon FL, Hoopes SP. Caffeine-induced psychosis. CNS Spectr. 2009 Mar;14(3):127-9. doi: 10.1017/s1092852900020101. PMID: 19407709.[cited 2021 Dec 7]
19. Levy MI, Davis BM, Mohs RC, Trigos GC, Mathé AA, Davis KL. (1983) Gamma-hydroxybutyrate in the treatment of schizophrenia. Psychiatry Res 9:1–8. [cited 2021 Dec 7]
20. Peet M, Brind J, Ramchand CN, Shah S, Vankar GK. Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia. Schizophr Res. 2001 Apr 30;49(3):243-51. doi: 10.1016/s0920-9964(00)00083-9. PMID: 11356585. [cited 2021 Dec 7]
21. Morris JA. Schizophrenia, bacterial toxins and the genetics of redundancy. Med Hypotheses. 1996 Apr;46(4):362-6. doi: 10.1016/s0306-9877(96)90188-7. PMID: 8733166. [cited 2021 Dec 7]
22. Al Osman M, Yang F, Massey IY. Exposure routes and health effects of heavy metals on children. Biometals. 2019 Aug;32(4):563-573. doi: 10.1007/s10534-019-00193-5. Epub 2019 Apr 2. PMID: 30941546.[cited 2021 Dec 7]
23. Ergün C, Urhan M, Ayer A. A review on the relationship between gluten and schizophrenia: Is gluten the cause? Nutr Neurosci. 2018 Sep;21(7):455-466. doi: 10.1080/1028415X.2017.1313569. Epub 2017 Apr 9. PMID: 28393621. [cited 2022 June 27]